ClinicalTrials.govpublic full text
Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities
tardive dyskinesia, intellectual disability, developmental disabilities, valbenazine, movement disorders, antipsychotic medication adverse effects, abnormal involuntary movement scale, quality of life, adaptive behavior, caregiver burden, selective vesicular monoamine transporter 2 inhibitor, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 909589
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.